{"id":"https://openalex.org/W2944103205","doi":"https://doi.org/10.1007/s13318-019-00558-8","title":"Pharmacokinetics and Safety of a Diclofenac Sodium 75 mg/1 mL Solution (Akis\u00ae/Dicloin\u00ae) Administered as a Single Intravenous Bolus Injection in Healthy Men and Women","display_name":"Pharmacokinetics and Safety of a Diclofenac Sodium 75 mg/1 mL Solution (Akis\u00ae/Dicloin\u00ae) Administered as a Single Intravenous Bolus Injection in Healthy Men and Women","publication_year":2019,"publication_date":"2019-05-10","ids":{"openalex":"https://openalex.org/W2944103205","doi":"https://doi.org/10.1007/s13318-019-00558-8","mag":"2944103205","pmid":"https://pubmed.ncbi.nlm.nih.gov/31077065","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6746683"},"language":"en","primary_location":{"id":"doi:10.1007/s13318-019-00558-8","doi":"https://doi.org/10.1007/s13318-019-00558-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13318-019-00558-8","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13318-019-00558-8.pdf","source":{"id":"https://openalex.org/S204244929","display_name":"European Journal of Drug Metabolism and Pharmacokinetics","issn_l":"0378-7966","issn":["0378-7966","2107-0180"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Drug Metabolism and Pharmacokinetics","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://link.springer.com/content/pdf/10.1007/s13318-019-00558-8.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082249757","display_name":"Chiara Leuratti","orcid":"https://orcid.org/0000-0001-5594-6029","observed_orcids":["https://orcid.org/0000-0001-5594-6029"]},"institutions":[{"id":"https://openalex.org/I4405267631","display_name":"CROSS Research SA (Switzerland)","ror":"https://ror.org/03nqjwm69","country_code":"CH","type":"company","lineage":["https://openalex.org/I4405267631"]}],"countries":["CH"],"is_corresponding":true,"raw_author_name":"Chiara Leuratti","raw_affiliation_strings":["CROSS Research S.A., via F.A. Giorgioli 14, 6864, Arzo, Switzerland. chiara.leuratti@croalliance.com","CROSS Research S.A., via F.A. Giorgioli 14, 6864, Arzo, Switzerland"],"raw_orcid":"https://orcid.org/0000-0001-5594-6029","affiliations":[{"raw_affiliation_string":"CROSS Research S.A., via F.A. Giorgioli 14, 6864, Arzo, Switzerland. chiara.leuratti@croalliance.com","institution_ids":["https://openalex.org/I4405267631"]},{"raw_affiliation_string":"CROSS Research S.A., via F.A. Giorgioli 14, 6864, Arzo, Switzerland","institution_ids":["https://openalex.org/I4405267631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030190033","display_name":"Luca Loprete","orcid":"https://orcid.org/0000-0001-7616-6232","observed_orcids":["https://orcid.org/0000-0001-7616-6232"]},"institutions":[{"id":"https://openalex.org/I4210163806","display_name":"Galderma (Switzerland)","ror":"https://ror.org/05fswdm20","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210163806"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Luca Loprete","raw_affiliation_strings":["CROSS Metrics S.A., via F.A. Giorgioli 14, 6864, Arzo, Switzerland","Galderma S.A., Rue d'Entre-deux-Villes 10, 1814, La Tour-De-Peilz, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CROSS Metrics S.A., via F.A. Giorgioli 14, 6864, Arzo, Switzerland","institution_ids":[]},{"raw_affiliation_string":"Galderma S.A., Rue d'Entre-deux-Villes 10, 1814, La Tour-De-Peilz, Switzerland","institution_ids":["https://openalex.org/I4210163806"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Matteo Rossini","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210163806","display_name":"Galderma (Switzerland)","ror":"https://ror.org/05fswdm20","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210163806"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Matteo Rossini","raw_affiliation_strings":["CROSS Metrics S.A., via F.A. Giorgioli 14, 6864, Arzo, Switzerland","Galderma S.A., Rue d'Entre-deux-Villes 10, 1814, La Tour-De-Peilz, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CROSS Metrics S.A., via F.A. Giorgioli 14, 6864, Arzo, Switzerland","institution_ids":[]},{"raw_affiliation_string":"Galderma S.A., Rue d'Entre-deux-Villes 10, 1814, La Tour-De-Peilz, Switzerland","institution_ids":["https://openalex.org/I4210163806"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033185007","display_name":"Valeria Frangione","orcid":"https://orcid.org/0000-0003-0465-8953","observed_orcids":["https://orcid.org/0000-0003-0465-8953"]},"institutions":[{"id":"https://openalex.org/I4210152331","display_name":"IBSA Institut Biochimique (Switzerland)","ror":"https://ror.org/051tj3a26","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210152331"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Valeria Frangione","raw_affiliation_strings":["IBSA Institut Biochimique S.A., Via del Piano, 6915, Pambio-Noranco, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IBSA Institut Biochimique S.A., Via del Piano, 6915, Pambio-Noranco, Switzerland","institution_ids":["https://openalex.org/I4210152331"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044692446","display_name":"Stefano Rovati","orcid":"https://orcid.org/0000-0001-8628-8364","observed_orcids":["https://orcid.org/0000-0001-8628-8364"]},"institutions":[{"id":"https://openalex.org/I4210152331","display_name":"IBSA Institut Biochimique (Switzerland)","ror":"https://ror.org/051tj3a26","country_code":"CH","type":"company","lineage":["https://openalex.org/I4210152331"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Stefano Rovati","raw_affiliation_strings":["IBSA Institut Biochimique S.A., Via del Piano, 6915, Pambio-Noranco, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IBSA Institut Biochimique S.A., Via del Piano, 6915, Pambio-Noranco, Switzerland","institution_ids":["https://openalex.org/I4210152331"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027823359","display_name":"Milko Massimiliano Radicioni","orcid":"https://orcid.org/0000-0002-3940-8375","observed_orcids":["https://orcid.org/0000-0002-3940-8375"]},"institutions":[{"id":"https://openalex.org/I4405267631","display_name":"CROSS Research SA (Switzerland)","ror":"https://ror.org/03nqjwm69","country_code":"CH","type":"company","lineage":["https://openalex.org/I4405267631"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Milko Radicioni","raw_affiliation_strings":["CROSS Research S.A., via F.A. Giorgioli 14, 6864, Arzo, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CROSS Research S.A., via F.A. Giorgioli 14, 6864, Arzo, Switzerland","institution_ids":["https://openalex.org/I4405267631"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5082249757"],"corresponding_institution_ids":["https://openalex.org/I4405267631"],"apc_list":{"value":3140,"currency":"USD","value_usd":3140},"apc_paid":{"value":3140,"currency":"USD","value_usd":3140},"fwci":0.8587,"has_fulltext":true,"cited_by_count":11,"citation_normalized_percentile":{"value":0.69595723,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"44","issue":"5","first_page":"681","last_page":"689"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.24210000038146973,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.24210000038146973,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.21699999272823334,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.1363999992609024,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diclofenac-sodium","display_name":"diclofenac sodium","score":0.9980000257492065},{"id":"https://openalex.org/keywords/intravenous-bolus","display_name":"intravenous bolus","score":0.7429999709129333},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7960000038146973},{"id":"https://openalex.org/keywords/hydroxypropyl-beta-cyclodextrin","display_name":"hydroxypropyl-\u03b2-cyclodextrin","score":0.9539999961853027},{"id":"https://openalex.org/keywords/parenteral-formulations","display_name":"parenteral formulations","score":0.5149999856948853},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.5879999995231628},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.628000020980835},{"id":"https://openalex.org/keywords/intramuscular-administration","display_name":"intramuscular administration","score":0.5820000171661377},{"id":"https://openalex.org/keywords/auc-comparison","display_name":"AUC comparison","score":0.4779999852180481},{"id":"https://openalex.org/keywords/cmax","display_name":"Cmax","score":0.6119999885559082},{"id":"https://openalex.org/keywords/healthy-volunteers","display_name":"healthy volunteers","score":0.753000020980835},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5239999890327454},{"id":"https://openalex.org/keywords/non-inferiority","display_name":"non-inferiority","score":0.49399998784065247},{"id":"https://openalex.org/keywords/bioequivalence","display_name":"bioequivalence","score":0.503000020980835},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.3409999907016754}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8448400497436523},{"id":"https://openalex.org/C2908765736","wikidata":"https://www.wikidata.org/wiki/Q244408","display_name":"Diclofenac Sodium","level":2,"score":0.792354941368103},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.753307580947876},{"id":"https://openalex.org/C2779826273","wikidata":"https://www.wikidata.org/wiki/Q244408","display_name":"Diclofenac","level":2,"score":0.707848072052002},{"id":"https://openalex.org/C43376680","wikidata":"https://www.wikidata.org/wiki/Q6580786","display_name":"Bolus (digestion)","level":2,"score":0.6536386013031006},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6078962087631226},{"id":"https://openalex.org/C87813604","wikidata":"https://www.wikidata.org/wiki/Q1242899","display_name":"Crossover study","level":4,"score":0.6071153283119202},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.48254865407943726},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.445488303899765},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2032211422920227},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.12846148014068604},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000073738","descriptor_name":"2-Hydroxypropyl-beta-cyclodextrin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000073738","descriptor_name":"2-Hydroxypropyl-beta-cyclodextrin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000073738","descriptor_name":"2-Hydroxypropyl-beta-cyclodextrin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000894","descriptor_name":"Anti-Inflammatory Agents, Non-Steroidal","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D001682","descriptor_name":"Biological Availability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004008","descriptor_name":"Diclofenac","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004008","descriptor_name":"Diclofenac","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D004008","descriptor_name":"Diclofenac","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007273","descriptor_name":"Injections, Intramuscular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007275","descriptor_name":"Injections, Intravenous","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018592","descriptor_name":"Cross-Over Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1007/s13318-019-00558-8","doi":"https://doi.org/10.1007/s13318-019-00558-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13318-019-00558-8","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13318-019-00558-8.pdf","source":{"id":"https://openalex.org/S204244929","display_name":"European Journal of Drug Metabolism and Pharmacokinetics","issn_l":"0378-7966","issn":["0378-7966","2107-0180"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Drug Metabolism and Pharmacokinetics","raw_type":"journal-article"},{"id":"pmid:31077065","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31077065","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of drug metabolism and pharmacokinetics","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6746683","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6746683/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Eur J Drug Metab Pharmacokinet","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1007/s13318-019-00558-8","doi":"https://doi.org/10.1007/s13318-019-00558-8","is_oa":true,"landing_page_url":"https://doi.org/10.1007/s13318-019-00558-8","pdf_url":"https://link.springer.com/content/pdf/10.1007/s13318-019-00558-8.pdf","source":{"id":"https://openalex.org/S204244929","display_name":"European Journal of Drug Metabolism and Pharmacokinetics","issn_l":"0378-7966","issn":["0378-7966","2107-0180"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320330","host_organization_name":"Adis, Springer Healthcare","host_organization_lineage":["https://openalex.org/P4310320330","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Adis, Springer Healthcare","Springer Nature"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Drug Metabolism and Pharmacokinetics","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2944103205.pdf","grobid_xml":"https://content.openalex.org/works/W2944103205.grobid-xml"},"referenced_works_count":10,"referenced_works":["https://openalex.org/W355643970","https://openalex.org/W1075774232","https://openalex.org/W2028962035","https://openalex.org/W2040489008","https://openalex.org/W2057979763","https://openalex.org/W2073925912","https://openalex.org/W2135665676","https://openalex.org/W2166939717","https://openalex.org/W2257876134","https://openalex.org/W4211036686"],"related_works":["https://openalex.org/W2108342592","https://openalex.org/W2082434002","https://openalex.org/W2120960951","https://openalex.org/W43382215","https://openalex.org/W2005491182","https://openalex.org/W1976519391","https://openalex.org/W1999035416","https://openalex.org/W2079215071","https://openalex.org/W2112985605","https://openalex.org/W2028962035"],"abstract_inverted_index":{"A":[0],"1-mL":[1],"aqueous":[2],"solution":[3,53,149,313],"for":[4,16,29,296,338],"parenteral":[5,58],"injection":[6],"containing":[7],"diclofenac":[8,43,59,88,111,121,138,154,175],"sodium":[9,89,122,176,309],"and":[10,18,42,84,115,272,290,331,341],"hydroxypropyl-\u03b2-cyclodextrin,":[11],"presently":[12],"on":[13],"the":[14,40,51,75,108,135,145,151,179,193,202,207,213,216,223,235,240,245,248,281,286],"market":[15],"intramuscular":[17,161],"subcutaneous":[19],"administration":[20,162,342],"(Akis":[21],"\u00ae":[22,24],"/Dicloin":[23],"),":[25],"was":[26,37,187,233,239,268,273,291,320],"further":[27],"developed":[28],"intravenous":[30],"(i.v.)":[31],"bolus":[32,49,118,143,182,319],"administration.":[33],"The":[34,61,170,259,323],"study":[35,62,72,105,132],"objective":[36],"to":[38,54,73,106,133,150,174,189,222,254,293],"compare":[39,134],"tolerability":[41,76],"pharmacokinetics":[44,109,136,152],"after":[45],"a":[46,93,129,140,156,164,297,304,316,328,332,345],"single":[47,94],"i.v.":[48,96,117,142,158,181,195,306,318],"of":[50,56,77,110,120,137,144,153,163,172,183,197,206,212,244,247],"investigational":[52],"those":[55],"other":[57,339],"products.":[60],"comprised":[63],"three":[64],"parts:":[65],"(i)":[66],"Part":[67,99,127],"1:":[68],"an":[69,101],"exploratory":[70],"dose-escalation":[71],"evaluate":[74,107],"25":[78],"mg/1":[79,82,86,124,147,185,311],"mL,":[80,200],"50":[81],"mL":[83,87,148,167,186,283,288,300,312],"75":[85,123,146,165,184,198,298,310],"formulations":[90],"administered":[91,314],"as":[92,238,303,315],"5-s":[95,141,180,317],"bolus;":[97],"(ii)":[98],"2:":[100],"exploratory,":[102],"randomised,":[103],"crossover":[104,131],"following":[112,139,155],"5-,":[113],"15-,":[114],"30-s":[116],"injections":[119],"mL;":[125],"(iii)":[126],"3:":[128],"randomised":[130],"30-min":[157,194],"infusion":[159,196],"or":[160],"mg/3":[166,199],"reference":[168],"formulation.":[169],"extent":[171],"exposure":[173],"afforded":[177],"by":[178,192],"equivalent":[188],"that":[190],"provided":[191],"since":[201],"90%":[203,241],"confidence":[204,242],"interval":[205,243],"geometric":[208],"mean":[209],"ratio":[210],"(GMR)":[211],"area":[214],"under":[215],"curve":[217],"(AUC)":[218],"from":[219,250],"time":[220,227,251],"0":[221,252],"last":[224],"plasma":[225,262],"concentration":[226,263,334],"t":[228,231],"(AUC":[229,256],"0-":[230],")":[232,267],"within":[234],"limits":[236],"80.00\u2013125.00%,":[237],"GMR":[246],"AUC":[249],"extrapolated":[253],"infinity":[255],"0-\u221e":[257],").":[258],"maximum":[260],"observed":[261],"(":[264],"C":[265],"max":[266],"approximately":[269],"2.7-fold":[270],"higher":[271,333],"achieved":[274],"earlier":[275],"(0.05":[276],"vs.":[277],"0.50":[278],"h)":[279],"with":[280,285],"1":[282],"than":[284,336],"3":[287],"formulation,":[289],"similar":[292],"data":[294],"published":[295],"mg/2":[299],"formulation":[301],"given":[302],"15-s":[305],"bolus.":[307],"Diclofenac":[308],"well":[321],"tolerated.":[322],"pharmacokinetic":[324],"profile,":[325],"which":[326],"showed":[327],"faster":[329],"onset":[330],"peak":[335],"seen":[337],"products":[340],"routes,":[343],"suggests":[344],"superior":[346],"analgesic":[347],"effect.":[348]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2019-05-16T00:00:00"}